We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Name them.... you can’t can you?
Also not sure how many holders with SVS selling for the first time, who can now get access to some money after its collapse
Right PL you're right I'm wrong. There is no competition to AVCT and there will be no competition to AVCT's test.
When it is released the SP will go into the stratosphere.
Why do you think with all this good news that the SP does not move?
(And by the way I was not concerned with the 10% SP drop on Monday per se. I was concerned that the SP was so fragile that it could fall 10% just because 2, tiny, inferior tests were brought to market. That was my point.)
@wyndrum - there has been a seller. My guess - placement shares being off loaded above 130p
Ophidian
Doing this again, bed wetter? Name them... hint, it’s not Optigene.
GKB, that's fair enough, however the next RNS I was expecting was the validation/test is ready one which I think most here thought was imminent but there does seem to be an acceptance now that it is in fact weeks away.
I'm not wrong about the SP though. Don't you think it at least a bit odd that every positive RNS over the last 2-3 weeks has made no discernible difference to the SP? MM's can't manipulate (which is code for ignoring supply and demand) for weeks on end. The MM' excuse just seems very trite to me. Which is why I am trying to figure out why the SP s not at least pushing forward. Something is holding it back and I can think it is the competition that will be available when AVCT are ready. if you have another view then I'd like to hear it.
Its puzzling to me why anybody thinks this stock is a traders "dream".
It has low volatility, (and what volatility there is generated by random,i n time terms, RNS's) high spread, and small, with potential for manipulation, share pool.
If its just a matter of a few weeks for the share price to have the potential to double, triple whatever, then why is the Sp not further ahead?
Just as an example Boohoo after their fall, if the update in Sept is as positive as many believe it will be, even with the potential bad news hanging over them, people are buying in for an 50-75% gain in the short term. (7 weeks away)
So why, when there is another positive brick in the wall with today's AVCT announcement, does the SP effectively not move (128p to sell which was yesterdays close)?
There is no doubt that AVCT will produce a test, I believe the uncertainty and reluctance of a sustained rise in the SP is due to timing. By the time AVCT release their test , the market may be flooded with similar tests.
That to me is the issue and I think the last few RNS's have all been holding/propping up the SP, trying to buy time.
But as I said the clock is ticking.
The quote wasn’t aimed at anyone in particular, it’s just one that I remembered from the large amount of threads started between 7-8am. I can’t argue with anything you have just said there PL, my aim was to temper the expectations of people that think every RNS is going to send the SP up like a rocket. Markets like concrete evidence and even better with numbers attached. PI’s have very little say on a share price when when there are hundreds of millions of shares valued where Avacta’s are at. It’s the institutional investors that will make the difference and with the money they are playing with, they prefer waiting for a guaranteed 50% rise than a ‘potential’ 200%.
For PI’s prepared to wait, this is great news but unfortunately it’s just a little bit longer until we get to reap the rewards of patience.
100% agree PL75. The fact Sir Al has congratulated his staff IMO means in terms of development the product is ready. It is now onto approvals. Each piece of the jigsaw is falling into line and I have no doubts we will see millions of these tests. I really could not care less what the price movement is today. Any real investor is looking beyond the next few trading days. If you look beyond to even 6 weeks from now, I believe we will be approved by all the necessary bodies and will be ready to sell the test. That's how close we are. It is not this time next year Rodney, this is this time in 6 weeks !
Hi there, that was me that said that, not because I was expecting a leap in the price, but because it was a great RNS. Do you think I’m fussed about a short term share price? In the past I’ve criticised the news, I don’t believe we’ll ever hear another thing about the neutralising therapy, that was a give away and no news at all.
Today’s news is huge. Condor is the fast track to approvals and procurement and we’re signed up with a large scale manufacturing partner that can produce tests in the millions. It’s evidence the test is good enough, otherwise it wouldn’t have been accepted. It’s derisked and for me, that’s all I needed to hear. The share price can catch up whenever it likes, but we’re on the way to great things here.
Its been derisked heavily. Great time to buy.
We had to close the gap that is now done, should see steady progress now.
A little more info from the RNS means I had underestimated the delay from Optimisation with Cytiva dropping the ball. I will update the timeline with the minor change and re-post later on.
Ophidian
Went even worse than I thought! I presumed it would climb but stay in the recent bracket of 125-150ish. It’s dropped almost immediately with barely any spike after the ‘Now THIS is an RNS’ brigade were predicting huge things.
Validation, then followed by sales data and this will fly no doubt. Just remember, the majority of people that will make a share price change significantly, when the company has 250million shares, want concrete evidence and data. This is great news and the markets will monitor but not move on it just yet.
Not sure what price LSE is seeing but HL is showing £1.30 to sell now
Let the 10%s. Go
This will rise steadily through the day
Boris Johnson has been sacked from jobs for making things up. Just saying.
Boris's track-and-trace app was described as world class. Just saying.
There should be a big premium developed on this share in the coming days. Those with conviction had an overriding sense it would turn out well based on the quality of the company and what had been said by them. Now they are joined by those who will have had their doubts put to rest. The test is coming, they gave guaged that they could likely need millions capacity per week and have put arrangements in place for that. And most of all the CEO describes his team as world class - a sort of giddy on fumes comment from a yorkshiremen and strange given the last step was actually performed by Cytiva. It reflects a palpable excitement and effusiveness and one would only use it if what was about to bring to market was world class. World class teams produce world class products and this world class product will meet a dire need and put a rocket under rhe sp.
Indeed, plenty newsflow to come, this is just the start... BAMS validation, more manufacturing partners, LFD validation, CE marking, approvals, SALES IN THE MILLIONS, that kind of thing...
Great RNS. Fantastic partner. Well done to all holders who have ignored all the noise. BAMS and the LFT milestones are stacking up nicely now
Trading at £1.40 on Level 2
@Chengdo, here to make money my friend and will do so again this morning. Far as i'm concerned it's a given that massive production of cheap test strips are going to be required. What I want to see is the confirmation of these test with Cytiva, simple!
It's a positive RNS, no doubt about it, however it is a delay to their original schedule & there isn't a specific timetable for launch yet - it's just as soon as possible... Ultimately, technical data & clinical validation is all that matters here, as you can see from Sona Nanotech, once those are confirmed then the share price will rocket... until then it'll be sub £1.50 IMO.
If not I will be buying more as we seem to be moving down track quickly.
I didn’t expect this already. Not ramping just like Avacta business style.
This could be game changer to our everyday lives.